Gennaro Ciliberto is a Full Professor of Molecular Biology, University of Catanzaro “Magna Graecia,” since 1995. He has over 25 years of research management experience. In particular, his experience at Merck Sharp and Dohme research centre IRBM P. Angeletti in Pomezia (Rome) from 1991-2009 included responsibilities for several early drug discovery programs (target identification to phase I clinical trials), membership of several decision-making committees, and Site Head and Managing Director for 200 employees (2006-2009).
In November 2009, he co-founded Takis s.r.l., a spin-off of the IRBM P. Angeletti, with the main focus on research and development in Oncology. In March 2012, he was appointed Scientific Director of IRCSS Istituto Nazionale Tumori, Senatore “G. Pascale” Napoli. He has over 200 publications in the areas of cancer stem cell therapy, cancer vaccines, somatic gene therapy, structure and function of cytokines (e.g. IL6), and transcriptional control of acute phase response.
Conference Session Materials
This section has yet to be updated by the speaker.